Skip to content

Kaiser Permanente Northern California

Does Kaiser Permanente Northern California cover Zepbound for Weight Loss?

Yes. Kaiser Permanente Northern California covers Zepbound for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.

Policy document

  • Standard Commercial Guidelines 6 1 26 Excerpted

    Kaiser Permanente Northern California · PA policy · Employer

    Effective June 1, 2026. Verified June 5, 2026.

    View PDF Download Original insurer source
  • Employer: Covered with requirements. See the qualification pathways below.

Earliest policy review June 5, 2026. How we verify · Check your exact plan

Full requirements: Zepbound for Weight Loss (1 plan type)

Applies to Employer plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Initial approval — BMI ≥ 30 kg/m2 (non-Asian)

All of:

  • Age 18 or older
  • BMI ≥ 30 kg/m2
  • Actively enrolled in exercise and caloric reduction program
  • Not using Zepbound concurrently with a GLP-1 receptor agonist

Initial approval — Asian patient BMI ≥ 27.5 kg/m2

All of:

  • Age 18 or older
  • Asian patient with BMI ≥ 27.5 kg/m2
  • Actively enrolled in exercise and caloric reduction program
  • Not using Zepbound concurrently with a GLP-1 receptor agonist

Initial approval — BMI ≥ 27 kg/m2 with comorbidity (non-Asian)

All of:

  • Age 18 or older
  • BMI ≥ 27 kg/m2
  • At least one weight-related comorbidity (hypertension, T2DM, dyslipidemia, cardiovascular disease, CAD, sleep apnea, osteoarthritis of the knee, polycystic ovarian syndrome, NASH/NAFLD, asthma, COPD)
  • Actively enrolled in exercise and caloric reduction program
  • Not using Zepbound concurrently with a GLP-1 receptor agonist

Initial approval — Asian patient BMI ≥ 25 kg/m2 with comorbidity

All of:

  • Age 18 or older
  • Asian patient with BMI ≥ 25 kg/m2
  • At least one weight-related comorbidity (hypertension, T2DM, dyslipidemia, cardiovascular disease, CAD, sleep apnea, osteoarthritis of the knee, polycystic ovarian syndrome, NASH/NAFLD, asthma, COPD)
  • Actively enrolled in exercise and caloric reduction program
  • Not using Zepbound concurrently with a GLP-1 receptor agonist

Documentation to bring

  • Baseline BMI documentation (≥ 30 kg/m2, or ≥ 27.5 kg/m2 for Asian patients, or ≥ 27 kg/m2 with comorbidity, or ≥ 25 kg/m2 for Asian patients with comorbidity)
  • Documentation of at least one weight-related comorbidity if using lower BMI threshold pathway
  • Documentation of active enrollment in exercise and caloric reduction program
  • Confirmation that Zepbound will not be used concurrently with a GLP-1 receptor agonist
  • At renewal: documentation of at least 5% weight loss from baseline body weight

Approval and renewal

  • Renewal: Patient must have achieved or maintained at least 5% weight loss from baseline (pre-treatment) body weight. BMI eligibility thresholds are re-verified at renewal (same thresholds as initial). Age and lifestyle program enrollment requirements from initial criteria are not explicitly re-verified at renewal. Concurrent GLP-1 use remains prohibited.

Not covered when

  • Concurrent use of a GLP-1 receptor agonist (liraglutide, semaglutide, exenatide, exenatide extended-release)

Policy note: For Asian patients, the BMI threshold without comorbidity is 27.5 kg/m2 and with comorbidity is 25 kg/m2. For non-Asian patients, BMI threshold without comorbidity is 30 kg/m2 and with comorbidity is 27 kg/m2. At renewal, the BMI eligibility thresholds are re-verified using the same criteria as initial approval, plus the 5% weight loss requirement. The lifestyle program enrollment and age requirement are present in initial criteria but not explicitly listed in renewal criteria.

Policy effective June 1, 2026 · verified June 5, 2026 · source: Standard Commercial Guidelines 6 1 26 Excerpted · View policy document (PDF)

Open on its own page →

Questions people ask
Does Kaiser Permanente Northern California cover Zepbound?
Yes. Kaiser Permanente Northern California covers Zepbound for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.
What does Kaiser Permanente Northern California require to renew Zepbound?
Weight Loss — Applies to Employer plans. Patient must have achieved or maintained at least 5% weight loss from baseline (pre-treatment) body weight. BMI eligibility thresholds are re-verified at renewal (same thresholds as initial). Age and lifestyle program enrollment requirements from initial criteria are not explicitly re-verified at renewal. Concurrent GLP-1 use remains prohibited.
How current is this information?
The oldest review date among the policies on this page is June 5, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Also under Kaiser Permanente Northern California: Mounjaro, Ozempic, Wegovy

Zepbound under other plans: California Medicaid, Elevance Health, Kaiser Permanente Southern California, Molina Healthcare, Alabama Medicaid, Colorado Medicaid, Connecticut Medicaid, Delaware Medicaid

All insurance plans · All medications

Summary of Kaiser Permanente Northern California's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.